GWAS-related eQTLs across different cancer types
We identified 337,131 eQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
|
Cancer type
|
eQTL type
|
tagSNP
|
Gene position (hg19)
|
p-value
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCEC | cis | rs1577917 | 1 | rs12204015 | chr6:86598334 | SNHG5 | chr6:86386726-86388451:- | -0.44 | -5.74 | 4.93E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12204365 | chr6:86700532 | SNHG5 | chr6:86386726-86388451:- | -0.42 | -4.96 | 1.9E-6 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12205336 | chr6:86722367 | SNHG5 | chr6:86386726-86388451:- | -0.49 | -5.75 | 4.69E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12205548 | chr6:86759770 | SNHG5 | chr6:86386726-86388451:- | -0.51 | -5.84 | 3.02E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12207305 | chr6:86723502 | SNHG5 | chr6:86386726-86388451:- | -0.47 | -5.84 | 3.13E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12207610 | chr6:86688016 | SNHG5 | chr6:86386726-86388451:- | -0.45 | -5.37 | 2.92E-7 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12208493 | chr6:86662267 | SNHG5 | chr6:86386726-86388451:- | -0.51 | -5.83 | 3.25E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12209127 | chr6:86724427 | SNHG5 | chr6:86386726-86388451:- | -0.49 | -5.75 | 4.69E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12212733 | chr6:86726013 | SNHG5 | chr6:86386726-86388451:- | -0.44 | -5.34 | 3.34E-7 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12213149 | chr6:86668644 | SNHG5 | chr6:86386726-86388451:- | -0.51 | -5.83 | 3.25E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12213740 | chr6:86656733 | SNHG5 | chr6:86386726-86388451:- | -0.45 | -5.38 | 2.75E-7 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12215037 | chr6:86727631 | SNHG5 | chr6:86386726-86388451:- | -0.5 | -5.79 | 3.91E-8 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12216203 | chr6:86675301 | SNHG5 | chr6:86386726-86388451:- | -0.45 | -5.39 | 2.62E-7 | Response to antipsychotic treatment |
| UCEC | cis | rs1577917 | 1 | rs12216328 | chr6:86703418 | SNHG5 | chr6:86386726-86388451:- | -0.45 | -5.39 | 2.62E-7 | Response to antipsychotic treatment |
| UCEC | cis | rs12220777 | 1 | rs12220777 | chr10:81788104 | LOC219347 | chr10:81805991-81838949:- | -0.66 | -5.3 | 4.01E-7 | Chronic obstructive pulmonary disease-related biomarkers |